Virginia Telehealth Network

DEA Grants Fourth Temporary Extension of Flexibilities for Tele-Prescribing Controlled Substances Through 2026

The U.S. Drug Enforcement Administration (DEA), in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications, extending the current telemedicine flexibilities through December 31, 2026.    Telemedicine flexibilities regarding prescription of controlled medications include:  A DEA-registered practitioner can prescribe a Schedule II-V controlled substance […]

Read More… from DEA Grants Fourth Temporary Extension of Flexibilities for Tele-Prescribing Controlled Substances Through 2026

November 2025 Updates to Medicare Telehealth Policy

Recently, legislative and regulatory changes brought updates to Medicare telehealth policy, including a short-term government funding deal extending key telehealth flexibilities and lasting adjustments released in the 2026 Medicare Physician Fee Schedule (PFS) final rule. Shutdown Deal Extends Temporary Telehealth Flexibilities As part of the agreement that ended the government shutdown, Congress approved and the […]

Read More… from November 2025 Updates to Medicare Telehealth Policy